Related Experiment Video
Updated: May 15, 2026
06:11
A High-throughput Shigella-specific Bactericidal Assay
Published on: February 27, 2019
Recent progress towards development of a Shigella vaccine
Ana Isabel Camacho1, Juan Manuel Irache, Carlos Gamazo
1Department of Microbiology, University of Navarra, Pamplona, Spain.
Expert Review of Vaccines
|December 22, 2012
Summary
Developing a safe and effective vaccine for shigellosis dysentery in children is crucial. Subunit vaccine strategies, focusing on Shigella antigens and adjuvants, show promise for widespread vaccination campaigns.
Area of Science:
- Microbiology
- Immunology
- Vaccinology
Background:
- Shigellosis causes significant dysentery burden in children globally.
- No licensed vaccine is currently available to prevent shigellosis.
- Vaccine development is a public health priority for developing nations.
Purpose of the Study:
- To review current vaccine achievements for shigellosis.
- To focus on subunit vaccine strategies and future directions.
- To explore pathogenesis and immune response for vaccine design.
Main Methods:
- Literature review of vaccine research for shigellosis.
- Analysis of Shigella pathogenesis and host immune responses.
- Evaluation of subunit vaccine components (antigens and adjuvants).
Main Results:
- Subunit vaccine strategies are a key focus for shigellosis prevention.
- Understanding pathogenesis and immune response informs vaccine requirements.
- Appropriate antigen and adjuvant selection is vital for efficacy and safety.
Conclusions:
- Subunit vaccines hold promise for safe and effective shigellosis prevention.
- Optimized antigen-adjuvant combinations can improve vaccine delivery and uptake.
- Further research into subunit vaccine strategies is essential for global health.
Related Concept Videos
01:23Vaccine Production
Vaccine production involves a sequence of upstream and downstream processes to generate a safe and effective immunological product. It begins with cultivating microorganisms, such as viruses or bacteria, to obtain antigenic material. For viral vaccines, mammalian host cells are grown in bioreactors and subsequently infected with the target virus. The virus replicates within the host cells, which are lysed to release viral particles. This lysate is then clarified through filtration or...
01:18Bacterial Gastroenteritis
Bacterial gastroenteritis, characterized by diarrhea, abdominal cramps, and vomiting, is often caused by ingestion of contaminated food or water and is frequently associated with pathogenic Escherichia coli strains. These microbes exploit two principal mechanisms to inflict disease.Shiga toxin–producing E. coli, also referred to as STEC—notably O157:H7—release Shiga toxins that target ribosomes, blocking protein synthesis. The B subunit of the toxin binds the host glycolipid receptor...
01:29Microorganisms in Medicine and Therapeutics
Microorganisms play a fundamental role in vaccine development, gene therapy, and therapeutic production. Their biological properties are harnessed to advance medicine and public health. Beyond immunization, microorganisms contribute to gut health, antibiotic synthesis, and genetic disease treatment.Live Attenuated and Inactivated VaccinesLive attenuated vaccines, such as the measles, mumps, and rubella (MMR) vaccine, utilize weakened forms of pathogens to closely resemble natural infections.